Literature DB >> 2911801

Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy.

R Lindley1, A Bulman, P Parsons, R Phillips, K Henry, H Ellis.   

Abstract

A histopathologic review was undertaken of 293 patients with breast cancer treated by local tumor excision and radical radiotherapy. In a 6-year period, there were 37 local treatment failures with 16 deaths, and an additional 20 patients died without local recurrence. Pathologic data were available for 272 patients. Multivariate analysis indicated that the pathologic features in an invasive tumor most predictive for local recurrence were the combination of a high proportion of intraduct carcinoma with extensive necrosis (comedocarcinoma). Of 18 patients with these features, nine have had early local recurrence (a risk of 50% with these features vs 10% in those without), and four have died (a risk of 22% against 12%). Despite the short follow-up, the results already appear significant, and the study is ongoing. The importance of comedonecrosis in the intraduct component as a prognostic indicator in invasive carcinoma of the breast is not widely recognized and might constitute a relative contraindication to conservative treatment of the breast.

Entities:  

Mesh:

Year:  1989        PMID: 2911801

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Correlation between mammographic and sonographic findings and prognostic factors in patients with node-negative invasive breast cancer.

Authors:  H J Shin; H H Kim; M O Huh; M J Kim; A Yi; H Kim; B H Son; S H Ahn
Journal:  Br J Radiol       Date:  2010-08-03       Impact factor: 3.039

Review 2.  Risk factors and management of local recurrence following breast conservation surgery.

Authors:  R T Osteen
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

3.  Detection of intraductal component around invasive breast cancer using ultrasound: correlation with MRI and histopathological findings.

Authors:  Sangeetha Sundararajan; Eriko Tohno; Hiroshi Kamma; Ei Ueno; Manabu Minami
Journal:  Radiat Med       Date:  2006-02

4.  An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy.

Authors:  J Jacquemier; J M Kurtz; R Amalric; H Brandone; Y Ayme; J M Spitalier
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

Review 5.  Patient selection criteria for conservation surgery versus mastectomy: Memorial Hospital breast service experience.

Authors:  M P Moore; D W Kinne
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

Review 6.  Clinical decision-making in early breast cancer.

Authors:  C M Balch; S E Singletary; K I Bland
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

7.  Histopathological study of local residual carcinoma after simulated lumpectomy.

Authors:  S Haga; M Makita; T Shimizu; O Watanabe; H Imamura; T Kajiwara; M Fujibayashi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

8.  Impact of an extensive in situ component on the presence of residual disease in screen detected breast cancer.

Authors:  I D Campbell; J M Theaker; G T Royle; R Coddington; R Carpenter; A Herbert; I Moore; C Rubin; I Taylor; P B Guyer
Journal:  J R Soc Med       Date:  1991-11       Impact factor: 18.000

9.  DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy.

Authors:  H Beerman; B A Bonsing; M J van de Vijver; J Hermans; P M Kluin; R J Caspers; C J van de Velde; C J Cornelisse
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

10.  Standardized and reproducible methodology for the comprehensive and systematic assessment of surgical resection margins during breast-conserving surgery for invasive breast cancer.

Authors:  Stephen P Povoski; Rafael E Jimenez; Wenle P Wang; Ronald X Xu
Journal:  BMC Cancer       Date:  2009-07-27       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.